Chenodeoxycholic Acid-Amikacin Combination Enhances Eradication of Staphylococcus aureus.
Ontology highlight
ABSTRACT: The rise of antibiotic resistance and dearth of novel antibiotics have posed a serious health crisis worldwide. In this study, we screened a combination of antibiotics and nonantibiotics providing a viable strategy to solve this issue by broadening the antimicrobial spectrum. We found that chenodeoxycholic acid (CDCA), a cholic acid derivative of the traditional Chinese medicine (TCM) Tanreqing (TRQ), synergizes with amikacin against Staphylococcus aureus in vitro, and this synergistic killing was effective against diverse methicillin-resistant S. aureus (MRSA) variants, including small-colony variants (SCVs), biofilm strains, and persisters. The CDCA-amikacin combination protects a mouse model from S. aureus infections. Mechanistically, CDCA increases the uptake of aminoglyc
SUBMITTER: Cui K
PROVIDER: S-EPMC9927322 | biostudies-literature | 2023 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA